A 2025 narrative review published in the journal Nutrients on nutritional approaches to complement GLP-1 therapy noted that probiotic supplementation may be a promising adjunct to GLP-1 treatment, with potential benefits for both gut microbiome balance and digestive tolerability
Given these principally different modes of action, is it actually plausible that gutderived GLP1 should physiologically activate receptors within the CNS
Why do surgeons ask about GLP-1 medications
The FDA has issued specific warnings about compounded GLP-1 receptor agonists, including concerns about product quality and patient safety
This makes it a more favorable option from a safety standpoint, particularly for patients who are newly diagnosed and whose medication regimen is still being established
We asked nutritionists Some food companies, including Nestle and Conagra, are responding to the popularity of obesity and diabetes drugs by branding some products "GLP-1 Friendly." The labels target a growing number of consumers taking medicines such as Zepbound and Wegovy who may be looking for healthier, ready-made meals that minimize side-effects from the drugs